Troutman Pepper Advises Palvella Therapeutics in Reverse Merger with Pieris Pharmaceuticals and Concurrent Private Placement of $78.9 Million
Published on December 24, 2024
package for startups, early-stage, and fast-growing companies. Clients receive legal counsel, mentoring, relationship-building opportunities